Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model
在人性化、完全自体小鼠模型中推进精准肿瘤学
基本信息
- 批准号:10611842
- 负责人:
- 金额:$ 58.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-01 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:Adaptive Immune SystemAddressAnimalsAntigensAreaAutologousBiological ModelsBiologyBone MarrowCD34 geneCancer ModelCellsClinical OncologyCollaborationsColorectal CancerColorectal NeoplasmsCommunitiesCredentialingDevelopmentEarly DiagnosisEarly treatmentEvaluationExposure toFrequenciesFundingFutureGoalsGrantHumanHuman BiologyImmuneImmune responseImmune systemImmunocompetentImmunologic Deficiency SyndromesImmunological ModelsImmunotherapyIndividualInfrastructureInnate Immune SystemInstitutionLeukocytesLymphocyteMalignant NeoplasmsMalignant neoplasm of gastrointestinal tractMalignant neoplasm of pancreasMeasuresModalityModelingMonitorMorbidity - disease rateMusNeoplasm MetastasisOncologyPatient-Focused OutcomesPatientsPhenotypePre-Clinical ModelProgressive DiseaseRadiation therapyRegimenResearchResearch PersonnelResearch ProposalsResourcesSourceStructureSystemT cell receptor repertoire sequencingT cell responseT-LymphocyteTechniquesTherapeuticTissuesToxic effectTreatment ProtocolsTreatment-related toxicityVaccine DesignWorkanti-CTLA4anti-PD1 therapyanticancer researchantigen-specific T cellscancer immunobiologycancer immunotherapycancer therapycheckpoint therapyeffector T cellhuman modelhumanized mouseimmune checkpoint blockadeimprovedin vivo Modelmelanomamouse modelmutantneoantigensnovelpancreatic neoplasmpatient derived xenograft modelpatient responsepeptide based vaccinepeptide vaccinationpre-clinicalprecision oncologypredicting responseresponsesuccesstranslational oncologytreatment responsetumortumor growthvaccine strategy
项目摘要
Progress in the early detection and treatment of cancer requires accurate model systems to further evaluate
new, promising discoveries. Small animal, and in particular mouse, model systems are attractive to researchers
for numerous reasons, including their ease of use and well-described platforms. Immunotherapy has
revolutionized clinical oncology, but lacks pre-clinical models of the human immune system and human cancer
to investigate new modalities and limitations/toxicities of treatment regimens. The ability to grow human tumors
in immune-deficient mice (so-called patient-derived xenografts, or PDXs) allows researchers to work directly with
human cancer tissue in a controlled setting. However, PDX models are limited by their lack of an intact immune
system. The broad objective of this proposal is to validate an in vivo model to evaluate human tumors in the
context of a complete and intact human immune system in a completely personalized and autologous
fashion to study cancer immunotherapy. Herein, we propose to: (1) validate the ability of our humanized
system to serve as a model for cancer immunotherapy treatment response and toxicity in patients with
melanoma, including immunotherapy checkpoint blockade and vaccine strategies, and to (2) extend our current
work in melanoma by validating the ability to establish humanized mice and evaluate tumor growth and leukocyte
development in autologous human pancreatic and colorectal tumors established in humanized mice.
In each of these areas, we will leverage our multi-institutional team's individual expertise along with our
institutional infrastructure to maximize the success of the experimental aims. The results from this project will
made widely available to the general research community for future, hypothesis-driven research. Taken together,
the studies described in this research proposal will meet multiple goals and address several unmet needs
identified in this grant opportunity, thus significantly enhancing the applicability of a fully autologous and
immunocompetent precision model system for use in translational oncology research.
癌症早期发现和治疗的进展需要精确的模型系统来进一步评估
新的有希望的发现小动物,特别是小鼠,模型系统对研究人员具有吸引力
原因有很多,包括它们的易用性和描述良好的平台。免疫治疗已
革命性的临床肿瘤学,但缺乏人类免疫系统和人类癌症的临床前模型
研究治疗方案的新模式和局限性/毒性。人类肿瘤生长的能力
在免疫缺陷小鼠(所谓的患者来源的异种移植物,或PDX)中,
人类癌症组织的一种控制性的方法。然而,PDX模型受到缺乏完整免疫的限制
系统该提案的广泛目标是验证体内模型,以评估人类肿瘤的生物学特性。
在完全个性化和自体免疫系统中的完整和完整的人类免疫系统的背景下,
研究癌症免疫疗法的时尚。在此,我们建议:(1)验证我们的人性化的能力,
系统作为癌症免疫疗法治疗反应和毒性的模型,
黑色素瘤,包括免疫治疗检查点封锁和疫苗策略,并(2)扩大我们目前的
通过验证建立人源化小鼠和评估肿瘤生长和白细胞的能力,
在人源化小鼠中建立的自体人胰腺和结肠直肠肿瘤中的发育。
在每个领域,我们将利用我们的多机构团队的个人专长,沿着我们的
体制基础设施,以最大限度地成功的实验目标。该项目的成果将
广泛提供给一般研究界,用于未来的假设驱动的研究。综合起来看,
本研究计划中所描述的研究将满足多个目标,并解决几个尚未满足的需求
在这个赠款机会中确定,从而大大提高了完全自体和
用于转化肿瘤学研究的免疫活性精确模型系统。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ryan C Fields其他文献
Ryan C Fields的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ryan C Fields', 18)}}的其他基金
Biospecimen Acquisition, Processing, and Classification Unit
生物样本采集、处理和分类装置
- 批准号:
10904039 - 财政年份:2023
- 资助金额:
$ 58.7万 - 项目类别:
StARR Program in Cross-Disciplinary Oncology Clinician-Scientist Training
StARR 跨学科肿瘤学临床医生-科学家培训计划
- 批准号:
10592756 - 财政年份:2023
- 资助金额:
$ 58.7万 - 项目类别:
The role of RAMS11 in colorectal cancer progression and treatment resistance
RAMS11 在结直肠癌进展和治疗耐药中的作用
- 批准号:
10467047 - 财政年份:2021
- 资助金额:
$ 58.7万 - 项目类别:
The role of RAMS11 in colorectal cancer progression and treatment resistance
RAMS11 在结直肠癌进展和治疗耐药中的作用
- 批准号:
10298026 - 财政年份:2021
- 资助金额:
$ 58.7万 - 项目类别:
The role of RAMS11 in colorectal cancer progression and treatment resistance
RAMS11 在结直肠癌进展和治疗耐药中的作用
- 批准号:
10689094 - 财政年份:2021
- 资助金额:
$ 58.7万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 58.7万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 58.7万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 58.7万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 58.7万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 58.7万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 58.7万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 58.7万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 58.7万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 58.7万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 58.7万 - 项目类别:
Research Grant